Int J Radiat Oncol Biol Phys 2019 Oct 10
Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy.
Related Questions
For instance, are there
1. Specific Linac features, such as a certain MLC leaf width, 6-DOF couch, etc?
2. Requisite on board imaging/IGRT capabilit...
New answer by Radiation Oncologist at University of Washington School of Medicine (December 8, 2021)
I agree with Dr. @Yoshiya Yamada that in order to start an SBRT program, there got to be some minimum requirements.1. Expertise- Apart from the MD and physics expertise, ...
Is it better to sacrifice target coverage (reducing volume receiving 95-100% dose) or change to fSRS in order to meet cord constraints without having ...
New answer by Radiation Oncologist at Bon Secours Mercy Health (April 10, 2022)
Overall, the challenges of balancing target volume coverage versus protection of OARs are the same in the treatment of spine SRS. I have generally recommended that target volu...
Does your constraint differ based on region of the spinal cord?
New comment by Radiation Oncologist at Munson Medical Center ( November 1, 2023)
The area of the cord/cauda equina definitely matters with how aggressive you will go, for WHO Grade 1, 50.4/28 Fx is certainly adequate.
On a side note, anyone have t...
If so, do you modify your external beam dose?
New answer by Radiation Oncologist at Corewell Health (April 4, 2024)
Short answer: Yes, you can, and I do not modify my dose. I have no issues with this and have done it multiple times for patients who need more immediate symptom relief (pain, ...
New answer by Radiation Oncologist at Maimonides Cancer Center (October 2, 2024)
Drs. @Stea, @Butala, and @Schroeder, what is your perspective on employing bevacizumab as a salvage treatment for radiation-induced myelitis?
A patient who previously was treated to 30 Gy in 10 fraction from T2-T4 recently completed Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for progre...
New answer by (March 1, 2025)
This question will become more common as more patients undergo PSMA-based radiopharmaceutical therapy (RPT). The focus of this question seems to be related to the additional d...